Structure-function-rescue: the diverse nature of common p53 cancer mutants - PubMed
- ️Mon Jan 01 2007
Review
. 2007 Apr 2;26(15):2226-42.
doi: 10.1038/sj.onc.1210291.
Affiliations
- PMID: 17401432
- DOI: 10.1038/sj.onc.1210291
Review
Structure-function-rescue: the diverse nature of common p53 cancer mutants
A C Joerger et al. Oncogene. 2007.
Abstract
The tumor suppressor protein p53 is inactivated by mutation in about half of all human cancers. Most mutations are located in the DNA-binding domain of the protein. It is, therefore, important to understand the structure of p53 and how it responds to mutation, so as to predict the phenotypic response and cancer prognosis. In this review, we present recent structural and systematic functional data that elucidate the molecular basis of how p53 is inactivated by different types of cancer mutation. Intriguingly, common cancer mutants exhibit a variety of distinct local structural changes, while the overall structural scaffold is largely preserved. The diverse structural and energetic response to mutation determines: (i) the folding state of a particular mutant under physiological conditions; (ii) its affinity for the various p53 target DNA sequences; and (iii) its protein-protein interactions both within the p53 tetramer and with a multitude of regulatory proteins. Further, the structural details of individual mutants provide the basis for the design of specific and generic drugs for cancer therapy purposes. In combination with studies on second-site suppressor mutations, it appears that some mutants are ideal rescue candidates, whereas for others simple pharmacological rescue by small molecule drugs may not be successful.
Similar articles
-
Wallentine BD, Wang Y, Tretyachenko-Ladokhina V, Tan M, Senear DF, Luecke H. Wallentine BD, et al. Acta Crystallogr D Biol Crystallogr. 2013 Oct;69(Pt 10):2146-56. doi: 10.1107/S0907444913020830. Epub 2013 Sep 20. Acta Crystallogr D Biol Crystallogr. 2013. PMID: 24100332 Free PMC article.
-
Structural biology of the tumor suppressor p53 and cancer-associated mutants.
Joerger AC, Fersht AR. Joerger AC, et al. Adv Cancer Res. 2007;97:1-23. doi: 10.1016/S0065-230X(06)97001-8. Adv Cancer Res. 2007. PMID: 17419939 Review.
-
Suad O, Rozenberg H, Brosh R, Diskin-Posner Y, Kessler N, Shimon LJ, Frolow F, Liran A, Rotter V, Shakked Z. Suad O, et al. J Mol Biol. 2009 Jan 9;385(1):249-65. doi: 10.1016/j.jmb.2008.10.063. Epub 2008 Oct 30. J Mol Biol. 2009. PMID: 18996393
-
Kamaraj B, Bogaerts A. Kamaraj B, et al. PLoS One. 2015 Aug 5;10(8):e0134638. doi: 10.1371/journal.pone.0134638. eCollection 2015. PLoS One. 2015. PMID: 26244575 Free PMC article.
-
How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance.
Stiewe T, Haran TE. Stiewe T, et al. Drug Resist Updat. 2018 May;38:27-43. doi: 10.1016/j.drup.2018.05.001. Epub 2018 May 9. Drug Resist Updat. 2018. PMID: 29857816 Review.
Cited by
-
Blanden AR, Yu X, Loh SN, Levine AJ, Carpizo DR. Blanden AR, et al. Drug Discov Today. 2015 Nov;20(11):1391-7. doi: 10.1016/j.drudis.2015.07.006. Epub 2015 Jul 20. Drug Discov Today. 2015. PMID: 26205328 Free PMC article. Review.
-
p53 regulates cytoskeleton remodeling to suppress tumor progression.
Araki K, Ebata T, Guo AK, Tobiume K, Wolf SJ, Kawauchi K. Araki K, et al. Cell Mol Life Sci. 2015 Nov;72(21):4077-94. doi: 10.1007/s00018-015-1989-9. Epub 2015 Jul 24. Cell Mol Life Sci. 2015. PMID: 26206378 Free PMC article. Review.
-
Kalathiya U, Padariya M, Faktor J, Coyaud E, Alfaro JA, Fahraeus R, Hupp TR, Goodlett DR. Kalathiya U, et al. Biomolecules. 2021 Mar 4;11(3):382. doi: 10.3390/biom11030382. Biomolecules. 2021. PMID: 33806612 Free PMC article. Review.
-
Stephenson Clarke JR, Douglas LR, Duriez PJ, Balourdas DI, Joerger AC, Khadiullina R, Bulatov E, Baud MGJ. Stephenson Clarke JR, et al. ACS Pharmacol Transl Sci. 2022 Oct 11;5(11):1169-1180. doi: 10.1021/acsptsci.2c00164. eCollection 2022 Nov 11. ACS Pharmacol Transl Sci. 2022. PMID: 36407959 Free PMC article.
-
Burns JN, Turnage KC, Walker CA, Lieberman RL. Burns JN, et al. Biochemistry. 2011 Jul 5;50(26):5824-33. doi: 10.1021/bi200231x. Epub 2011 Jun 9. Biochemistry. 2011. PMID: 21612213 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous